Distraction Therapy Using Virtual Reality in Cardiac Rehabilitation
Launched by UNIVERSITY OF MALTA · Mar 25, 2025
Trial Information
Current as of May 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Cardiovascular disease is a leading cause of death and morbidity worldwide, with the WHO reporting 17.9 million of all global deaths in 2019 attributed to cardiovascular disease, with 7.4 million deaths attributed to coronary heart disease. In Europe, CVDs are estimated to cause close to 4 million deaths annually, generating a cost of 196 billion Euros/year. Cardiac rehabilitation, an intervention offered to the majority of patients who would have experience any cardiac event, includes several components delivered by a multi-disciplinary team. The components include health education, advice...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients who are suffering from any cardiac condition
- • Patients who have had a cardiac event
- • Patients referred for cardiac rehabilitation.
- Exclusion Criteria:
- • Patients with Atrial Fibrillation
- • Patients with an implantable cardioverter defibrillator
- • Patients with a pacemaker and
- • Patients who suffer from Vertigo
About University Of Malta
The University of Malta, a premier institution for higher education and research in the Mediterranean region, is committed to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a multidisciplinary approach, the University leverages its extensive expertise in various fields, including medicine, pharmacy, and biomedical sciences, to conduct rigorous and ethically sound research. By fostering collaboration among academic, clinical, and industry partners, the University of Malta aims to translate scientific discoveries into practical applications, ultimately enhancing patient care and contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Imsida, , Malta
Patients applied
Trial Officials
Dr Anabel Sciriha, PhD
Principal Investigator
University of Malta
Dr Stephen Lungaro-Mifsud, PhD
Principal Investigator
University of Malta
Dr Tonio Agius, PhD
Principal Investigator
University of Malta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported